Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 202

1.

Effect of methylenetetrahydrofolate reductase 677C-->T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients.

Toffoli G, Russo A, Innocenti F, Corona G, Tumolo S, Sartor F, Mini E, Boiocchi M.

Int J Cancer. 2003 Jan 20;103(3):294-9.

2.

Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients.

Nakamura T, Saionji K, Hiejima Y, Hirayama H, Tago K, Takano H, Tajiri M, Hayashi K, Kawabata M, Funamizu M, Makita Y, Hata A.

Am J Kidney Dis. 2002 May;39(5):1032-9.

PMID:
11979347
4.

Interplay between methylenetetrahydrofolate reductase gene polymorphism 677C-->T and serum folate levels in determining hyperhomocysteinemia in heart transplant recipients.

Potena L, Grigioni F, Viggiani M, Magnani G, Sorbello S, Falchetti E, Sassi S, Mantovani V, Bacchi-Reggiani L, Magelli C, Branzi A.

J Heart Lung Transplant. 2001 Dec;20(12):1245-51.

PMID:
11744407
5.

Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients.

Födinger M, Wölfl G, Fischer G, Rasoul-Rockenschaub S, Schmid R, Hörl WH, Sunder-Plassmann G.

Kidney Int. 1999 Mar;55(3):1072-80.

6.

Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.

van Ede AE, Laan RF, Blom HJ, Boers GH, Haagsma CJ, Thomas CM, De Boo TM, van de Putte LB.

Rheumatology (Oxford). 2002 Jun;41(6):658-65.

PMID:
12048292
7.

Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease.

Andreassi MG, Botto N, Cocci F, Battaglia D, Antonioli E, Masetti S, Manfredi S, Colombo MG, Biagini A, Clerico A.

Hum Genet. 2003 Feb;112(2):171-7. Epub 2002 Nov 13.

PMID:
12522558
8.

Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism and the B-vitamins: a facet of nature-nurture interplay.

Herrmann W, Obeid R, Schorr H, Zarzour W, Geisel J.

Clin Chem Lab Med. 2003 Apr;41(4):547-53.

PMID:
12747601
9.

[Some aspects of homocysteine metabolism in hemodialysis patients].

Bednarek-Skublewska A, Buraczyńska M, Wawrzycki S, Baranowicz-Gaszczyk I, Ksiazek A.

Pol Arch Med Wewn. 2002 Nov;108(5):1041-7. Polish.

PMID:
12685244
10.

The relation between plasma homocysteine concentration and methylenetetrahydrofolate reductase gene polymorphism in pregnant women.

Murakami S, Matsubara N, Saitoh M, Miyakaw S, Shoji M, Kubo T.

J Obstet Gynaecol Res. 2001 Dec;27(6):349-52.

PMID:
11794822
11.

Association of two MTHFR polymorphisms with total homocysteine plasma levels in dialysis patients.

Födinger M, Buchmayer H, Heinz G, Papagiannopoulos M, Kletzmayr J, Perschl A, Vychytil A, Hörl WH, Sunder-Plassmann G.

Am J Kidney Dis. 2001 Jul;38(1):77-84.

PMID:
11431185
12.

Methionine synthase reductase 66A->G polymorphism is associated with increased plasma homocysteine concentration when combined with the homozygous methylenetetrahydrofolate reductase 677C->T variant.

Vaughn JD, Bailey LB, Shelnutt KP, Dunwoody KM, Maneval DR, Davis SR, Quinlivan EP, Gregory JF 3rd, Theriaque DW, Kauwell GP.

J Nutr. 2004 Nov;134(11):2985-90.

14.

Effect of the methylenetetrahydrofolate reductase 677C-->T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample.

de Bree A, Verschuren WM, Bjørke-Monsen AL, van der Put NM, Heil SG, Trijbels FJ, Blom HJ.

Am J Clin Nutr. 2003 Mar;77(3):687-93.

15.

[Association between gene polymorphisms of methylenetetrahydrofolate reductase and plasma homocysteine in Uygur patients with venous thromboembolism].

Abudureheman K, Mahemuti A, Xia YN, Hu XM.

Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Dec;40(12):1030-6. Chinese.

PMID:
23363719
16.

High dose methotrexate treatment in childhood ALL: pilot study on the impact of the MTHFR 677C>T and 1298A>C polymorphisms on MTX-related toxicity.

Haase R, Elsner K, Merkel N, Stiefel M, Mauz-Körholz C, Kramm CM, Körholz D.

Klin Padiatr. 2012 Apr;224(3):156-9. doi: 10.1055/s-0032-1304623. Epub 2012 Apr 18.

PMID:
22513795
17.

Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia.

Kishi S, Griener J, Cheng C, Das S, Cook EH, Pei D, Hudson M, Rubnitz J, Sandlund JT, Pui CH, Relling MV.

J Clin Oncol. 2003 Aug 15;21(16):3084-91.

PMID:
12915598
18.

Determinants of fasting and post-methionine homocysteine levels in families predisposed to hyperhomocysteinemia and premature vascular disease.

de Jong SC, Stehouwer CD, van den Berg M, Kostense PJ, Alders D, Jakobs C, Pals G, Rauwerda JA.

Arterioscler Thromb Vasc Biol. 1999 May;19(5):1316-24.

19.

MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis.

Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG; MTHFR Studies Collaboration Group.

JAMA. 2002 Oct 23-30;288(16):2023-31.

PMID:
12387655
20.

Homocysteine, MTHFR 677C-->T polymorphism, and risk of ischemic stroke: results of a meta-analysis.

Kelly PJ, Rosand J, Kistler JP, Shih VE, Silveira S, Plomaritoglou A, Furie KL.

Neurology. 2002 Aug 27;59(4):529-36.

PMID:
12196644

Supplemental Content

Support Center